Delhi HC extends relief to pharma firms over drug ban Usha Sharma Mar 22, 2016 Several companies went to the Delhi High Court to try to get the ban lifted
Cipla completes acquisition of generic businesses in US Sanjiv Das Feb 18, 2016 The acquisition will provide a launch pad to introduce Cipla’s pipeline of products in respiratory and injectables, among others,…
Cipla posts PAT of Rs 343 crore in Q3 FY1516 Sanjiv Das Feb 11, 2016 Domestic sales reduced to Rs 1,194 crore Cipla announced its unaudited consolidated financial results for the quarter ended…
Cipla patriarch Y K Hamied increases stake in company to over 20 per cent Sanjiv Das Feb 3, 2016 Acquires additional five per cent stake from his wife Farida Hamied In a move aimed at realignment of family shareholding, Cipla…
Cipla gets CCI nod to sell stake in consumer healthcare business Sanjiv Das Jan 29, 2016 In November last year, the company signed an agreement to sell 26.11 per cent in Cipla Health to FIL Capital Investments…
Cipla announces new management council Sanjiv Das Jan 8, 2016 Appoints Umang Vohra as its Global Chief Operating Officer Cipla announced the creation of a six member Management Council that…
Cipla launches anti-ageing skin care product Cutisera Usha Sharma Dec 4, 2015 Cutisera has been developed by Stempeutics Cipla has launched a novel “5 in 1” anti-ageing skin care product Cutisera developed…
Cipla ready to launch low-dose Efavirenz 400 mg Lakshmipriya Nair Nov 30, 2015 Studies found that the reduced dose of 400 mg Efavirenz was non-inferior to the standard dose of 600 mg Efavirenz dose
Cipla inks investment pact with FIL Capital Investment EP News Bureau Nov 30, 2015 No financial deals of the agreement were disclosed
Delhi HC tells govt not to take coercive steps against pharma cos Sanjiv Das Nov 25, 2015 Petitions were filed by pharma companies and an association of medicine manufacturing firms challenging the government's new drug…